Lipitor, also known as atorvastatin, is a medication used to lower cholesterol levels and reduce the risk of heart disease. According to the sources provided, there is no clear consensus on whether Lipitor is recommended for all diabetes patients.

The first source, Drug Patent Watch [1], provides information on the patent status of Lipitor but does not offer any medical advice or recommendations.

The second source, GoodRx [2], is a prescription drug price comparison website that includes a section on statins for diabetes treatment. While it provides information on Lipitor's effectiveness in reducing cholesterol levels and the risk of heart disease in diabetes patients, it does not make a blanket recommendation for all diabetes patients to take Lipitor. The website suggests that the decision to use Lipitor should be made on a case-by-case basis by a healthcare provider.

The third source, a study published in the National Library of Medicine [3], examines the use of statins in diabetes patients. The study found that statins, including Lipitor, can be effective in reducing the risk of cardiovascular disease in diabetes patients. However, the study also notes that the decision to prescribe statins should be based on individual patient factors, such as age, gender, and other health conditions.

In conclusion, while Lipitor may be effective in reducing the risk of heart disease in diabetes patients, there is no clear consensus on whether it is recommended for all diabetes patients. The decision to prescribe Lipitor or any other statin should be made on a case-by-case basis by a healthcare provider, taking into account individual patient factors.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] https://www.goodrx.com/classes/statins/diabetes-treatment
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369709/